Hemant Tongaonkar
Overview
Explore the profile of Hemant Tongaonkar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar P, Ranmale S, Mehta S, Tongaonkar H, Patel V, Singh A, et al.
J Ovarian Res
. 2023 Jun;
16(1):114.
PMID: 37322531
Background: Ovarian cancer is the third most prevalent cancer in Indian women. Relative frequency of High grade serous epithelial ovarian cancer (HGSOC) and its associated deaths are highest in India...
2.
Nagarajan G, Doshi P, Bardeskar N, Kulkarni A, Punamiya A, Tongaonkar H
J Surg Oncol
. 2023 May;
128(4):682-691.
PMID: 37183521
Background And Objectives: Despite surgical advances, postoperative complications persist, affecting oncologic outcomes and increasing treatment costs. It is important to identify a marker that can predict postoperative complications, which can...
3.
Kumar P, Ranmale S, Tongaonkar H, Mania-Pramanik J
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560531
High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a unique tumor microenvironment (TME) that extends to the peritoneal cavity. The immunosuppressive nature of TME imposes the major...
4.
Bakshi G, Tongaonkar H, Addla S, Menon S, Pradhan A, Kumar A, et al.
Indian J Cancer
. 2022 Mar;
59(Supplement):S19-S45.
PMID: 35343189
To gain insights on the diverse practice patterns and treatment pathways for prostate cancer (PC) in India, the Urological Cancer Foundation convened the first Indian survey to discuss all aspects...
5.
Wagh P, Kulkarni P, Kerkar S, Tongaonkar H, Chaudhari H, Warke H, et al.
Indian J Med Res
. 2021 Dec;
154(2):391-398.
PMID: 34854425
Background & Objectives: Aetiology of cervical cancer (CaCx) is multifactorial. Besides human papillomavirus (HPV) infection, many immunogenetic factors are involved in this complex process. The present study was carried out...
6.
Kumar P, Ranmale S, Tongaonkar H, Mehta S, Mania-Pramanik J
Indian J Med Microbiol
. 2021 May;
39(3):311-314.
PMID: 34016470
Purpose: Human papillomavirus (HPV), the causative agent of cervical cancer, is associated with several other epithelial malignancies. Previous reports on HPV infection and its association with ovarian cancer are highly...
7.
Wagh P, Kulkarni P, Kerkar S, Tongaonkar H, Deodhar K, Rekhi B, et al.
Indian J Med Microbiol
. 2020 May;
37(4):557-562.
PMID: 32436880
Background And Objectives: Human papillomavirus (HPV) is the causative agent of cervical cancer, a major cause of cancer mortality in Indian women. The current study was undertaken to add information...
8.
Chopra S, Mathew A, Maheshwari A, Bhatla N, Singh S, Rai B, et al.
J Glob Oncol
. 2018 Aug;
4:1-15.
PMID: 30085891
Standard guidelines for the management of early and locally advanced cervical cancer are available from various academic consortiums nationally and internationally. However, implementing standard-of-care treatment poses unique challenges within low-...
9.
Wagh P, Kulkarni P, Kerkar S, Warke H, Chaudhari H, Deodhar K, et al.
Indian J Med Microbiol
. 2018 Aug;
36(2):207-210.
PMID: 30084412
Background: Cervical cancer (CaCx) is the second most common cancer in Indian women. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) + 49 AA polymorphism is known to be associated with CaCx. Current...
10.
Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, et al.
J Clin Oncol
. 2018 Feb;
36(16):1548-1555.
PMID: 29432076
Purpose We compared the efficacy and toxicity of neoadjuvant chemotherapy followed by radical surgery versus standard cisplatin-based chemoradiation in patients with locally advanced squamous cervical cancer. Patients and Methods This...